Compass Pathways to participate in upcoming Oppenheimer investor conference
LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) — Compass Pathways plc (Nasdaq:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference at 2:00 pm ET on February 13, 2024.
Related news for (CMPS)
- How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition
- test
- Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved
- COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023